4//SEC Filing
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 4
Accession 0001213900-20-029553
CIK 0001158780other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:12 PM ET
Size
7.5 KB
Accession
0001213900-20-029553
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2020-09-29$9.76/sh+60,123$586,800→ 3,848,583 total - Purchase
Common Stock
2020-09-30$10.34/sh+139,006$1,437,322→ 3,987,589 total
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from approximately $9.42 to $10.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
- [F2]The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from approximately $10.13 to $10.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Documents
Issuer
PLURISTEM THERAPEUTICS INC
CIK 0001158780
Entity typeother
Related Parties
1- filerCIK 0001810117
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:12 PM ET
- Size
- 7.5 KB